Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity [NCT00279279].

    Wilkoff BL, Stern R, Williamson B, Wathen M, Holloman K, Fieberg A, Brown M.

    Trials. 2006 May 25;7:18.PMID: 16725036 [PubMed]Related articlesFree article

    2.

    Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.

    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK; PREPARE Study Investigators.

    J Am Coll Cardiol. 2008 Aug 12;52(7):541-50.PMID: 18687248 [PubMed - indexed for MEDLINE]Related articles

    3.

    A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.

    Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM; EMPIRIC Trial Investigators.

    J Am Coll Cardiol. 2006 Jul 18;48(2):330-9. Epub 2006 Jun 22.PMID: 16843184 [PubMed - indexed for MEDLINE]Related articles

    4.

    A trial design for evaluation of empiric programming of implantable cardioverter defibrillators to improve patient management.

    Morgan JM, Sterns LD, Hanson JL, Ousdigian KT, Otterness MF, Wilkoff BL.

    Curr Control Trials Cardiovasc Med. 2004 Nov 12;5(1):12.PMID: 15541169 [PubMed - as supplied by publisher]Related articlesFree article

    5.

    Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.

    Wilkoff BL, Hess M, Young J, Abraham WT.

    J Cardiovasc Electrophysiol. 2004 Sep;15(9):1002-9.PMID: 15363071 [PubMed - indexed for MEDLINE]Related articles

    6.
    7.

    Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.

    Circulation. 2007 May 8;115(18):2382-9. Epub 2007 Apr 30.PMID: 17470697 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial.

    Schwab JO, Gasparini M, Lunati M, Proclemer A, Kaup B, Santi E, Ligorio G, Klersy C, DE Sousa J, Okreglicki A, Arenal A, Wijffels M, Lemke B.

    J Cardiovasc Electrophysiol. 2009 Jun;20(6):663-6. Epub 2009 Jan 9.PMID: 19175450 [PubMed - indexed for MEDLINE]Related articles

    9.

    Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.

    Grimm W, Plachta E, Maisch B.

    Pacing Clin Electrophysiol. 2006 Jul;29(7):759-64.PMID: 16884513 [PubMed - indexed for MEDLINE]Related articles

    11.

    Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death.

    Boriani G, Gasparini M, Lunati M, Santini M, Landolina M, Vincenti A, Curnis A, Bocchiardo M, Padeletti L, Biffi M, Allaria L, Denaro A; InSync ICD Italian Registry Investigators.

    Am Heart J. 2006 Sep;152(3):527.e1-11.PMID: 16923425 [PubMed - indexed for MEDLINE]Related articles

    12.

    Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.

    Wathen M.

    Am Heart J. 2007 Apr;153(4 Suppl):44-52. Review.PMID: 17394902 [PubMed - indexed for MEDLINE]Related articles

    13.

    Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

    Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P.

    JAMA. 2007 Jul 25;298(4):405-12. Erratum in: JAMA. 2007 Oct 3;298(13):1516. PMID: 17652294 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A comparison of outcomes for patients receiving implantable cardioverter defibrillators for primary vs secondary-prevention.

    Giedrimas A, Giedrimiene D, Guertin D, White CM, Clyne CA, Kluger J.

    Conn Med. 2008 Jun-Jul;72(6):329-33.PMID: 18610705 [PubMed - indexed for MEDLINE]Related articles

    15.

    Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.

    Ypenburg C, van Erven L, Bleeker GB, Bax JJ, Bootsma M, Wijffels MC, van der Wall EE, Schalij MJ.

    J Am Coll Cardiol. 2006 Aug 1;48(3):464-70. Epub 2006 Jul 12.PMID: 16875970 [PubMed - indexed for MEDLINE]Related articles

    16.

    Implantable cardioverter-defibrillators in patients with left ventricular noncompaction.

    Kobza R, Jenni R, Erne P, Oechslin E, Duru F.

    Pacing Clin Electrophysiol. 2008 Apr;31(4):461-7.PMID: 18373765 [PubMed - indexed for MEDLINE]Related articles

    17.

    Evaluation and management of patients after implantable cardioverter-defibrillator shock.

    Gehi AK, Mehta D, Gomes JA.

    JAMA. 2006 Dec 20;296(23):2839-47. Review.PMID: 17179461 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.

    Albert CM, Rosenthal L, Calkins H, Steinberg JS, Ruskin JN, Wang P, Muller JE, Mittleman MA; TOVA Investigators.

    J Am Coll Cardiol. 2007 Dec 4;50(23):2233-40. Epub 2007 Nov 19.PMID: 18061071 [PubMed - indexed for MEDLINE]Related articles

    19.

    Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up.

    Karaoguz R, Maydanozcu S, Altun T, Güldal M, Akyürek O, Erol C.

    Int Heart J. 2006 Sep;47(5):763-73.PMID: 17106147 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

    Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators.

    J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65.PMID: 18387436 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data